
The reason why this famous TV doctor travelled 360 miles for surgery
The popular doctor from Kent underwent a second hip replacement in a hospital in Birmingham, 180 miles from home, to reduce his waiting time for treatment.
Now, the 72-year-old is speaking out about his surgery to show others awaiting treatment that they can also fast-track themselves if they're able to travel.
He took advantage of NHS Patient Choice after discovering a hospital that had almost no waiting list in the middle of the country.
Patient choice in the NHS provides patients with a legal right to choose where they receive their NHS healthcare services, including hospitals and other providers.
This will include many private hospitals if they provide services to the NHS and it does not cost the health service any more than a referral to a standard NHS hospital.
Speaking after his procedure, Hilary said: 'It was 180 miles from my home to Birmingham – but as it's a new hospital and it's a private hospital that treats NHS patients, they could get me in very quickly just with a referral from my GP.
'I'd do it again in a heartbeat for faster, quality care and highly recommend it. Patient Choice gives people real power – they just need to know it's there.
'The NHS App is going to be developed further to make this easier, and you can speak to your GP about your choices. You can choose to be referred to a private hospital at the outset, or you can switch hospitals like I did if you're facing delays locally.'
Hilary added that he was in a position to travel to make the operation sooner, adding: 'People don't want to be on a waiting list. They want to get on with their lives.
'Every single person who looked after me was amazing and couldn't have done any more. I am delighted with the result so far.'
It follows a poll of 1,000 adults suffering from chronic aches and pains – including those in need of hip and knee replacements – which revealed people in need of NHS operations would be willing to travel if it meant they could get the surgery they're desperate for, sooner.
The poll found respondents were happy to travel up to 60 miles if it meant they'd be seen within three to four weeks. One in 10 said they'd travel over 200 miles if they could get an NHS surgery within a month.
Of those polled, 36% are currently on a waiting list and 17% have been in a queue for more than a year.
Last year, statistics from the Liberal Democrats found that more than half of Brits using private healthcare say they decided not to use the NHS because of the length of the wait. More Trending
The research also found that one in seven people in the UK decided to turn to private medical care in the past year.
Among their reasons for doing so were the lack of availability in NHS treatments and the difference in quality of care.
But 54% of people cited the extent of the wait times as the main reason why they or a member of their family went private.
After the general election last year, Labour promised to return to meeting NHS performance standards, meaning 'patients should expect to wait no longer than 18 weeks from referral for consultant-led treatment of non-urgent health conditions'.
Get in touch with our news team by emailing us at webnews@metro.co.uk.
For more stories like this, check our news page.
MORE: Are millions of people actually faking being sick?
MORE: UK health warning after cases of deadly bacteria C. diff soar to 12 year high
MORE: NHS blood-carrying drones plan branded crazy by Londoners

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
2 hours ago
- The Independent
Retiring NHS England boss says cancer treatment on ‘cusp of golden era'
Cancer treatment is on the 'cusp of a golden era', according to the outgoing national medical director of NHS England. Professor Sir Stephen Powis said he expects the development of drugs harnessing the body's immune system to fight the disease will bring 'great advances in cancer survival'. In his final interview before retiring, Sir Stephen, 64, told The Times: 'We are at the cusp of a golden era in terms of the way we treat a range of cancers. 'For many cancers now, people should be confident that it's not a death sentence and that more treatments will become available.' He said the rise in people living longer and surviving cancers would continue, alongside cures for some forms of the disease. 'Our understanding of the genetics of cancer, of the way we can target cancers with particular drugs, and how we can use the body's own immune system to target cancers itself, is being revolutionised,' he said. He compared the progress made in treating cancer with the success in developing HIV/Aids treatments since he qualified as a doctor 40 years ago. He also said an increased focus on prevention will help eliminate certain types of cancer. 'We can't prevent all cancers, but there are cancers that we can certainly prevent,' he said, adding that he hopes lung cancers will become 'a lot rarer'. Cancer treatment, he said, would be 'driven by genetics' to become more individualised with the increased ability to pinpoint mutations in cells. His comments come as experts warned of a 'postcode lottery' in cancer services that focus on improving patients' quality of life and providing urgent care for people with the disease. The Royal College of Physicians (RCP), the Royal College of Radiologists (RCR), the UK Association of Supportive Care in Cancer (UKASCC) and the Association for Palliative Medicine (APM) have called for urgent investment in supportive and acute oncology. Sir Stephen warned the biggest challenge facing the NHS was the rise in elderly people and the economic pressure that is putting on the younger generation and the economy. Last week, Sir Stephen warned the British Medical Association (BMA) to 'think really hard' about whether industrial action by resident doctors – formerly junior doctors – planned for later this month is justified. He told The Times the walkout would cause 'tens of thousands of appointments and procedures' to be cancelled. The kidney specialist has served as national medical director since January 2018 and held the role throughout the Covid pandemic.


Glasgow Times
3 hours ago
- Glasgow Times
DIY heart monitor rolled out to cut hospital waiting lists
Traditional monitors can require lengthy set-up by a trained physiologist, but the new kit can be sent out to patients in the post for them to attach themselves at home. The device looks like a small patch which is stuck to the skin, while traditional devices see patients hooked up to numerous wires and monitors. After the new tool is worn for a few days, patients can post the device back – which will cut out the need for appointments to fit and remove the equipment. The information from the monitor is then assessed using an artificial intelligence (AI) tool, Cardiologs, which produces a report which is then assessed by either a physiologist or a doctor. It can be used to investigate conditions include atrial fibrillation, tachycardia or heart blocks. Frimley Health NHS Foundation Trust is the first hospital in the country to roll out the device, with hopes that the device will soon be used across other NHS trusts. The Trust said it will still use traditional devices, known as Holter monitors, on some patients who are in hospital, but many of those who are outside of hospital will be able to access the new ePatch, which is made by Philips, to use in the comfort of their own homes. The new ePatch (right) is said to be more convenient than a traditional Holter monitor (left) (Frimley Health NHS Foundation Trust/PA) It has estimated that the use of the patches will double its productivity levels for diagnosing heart rhythm problems. Dr Iain Sim, consultant cardiac electrophysiologist, told the PA news agency: 'The purpose of the device is to record the heart rhythm – to collect electrical signals from the heart – and to try to understand a bit about the patient and what they are experiencing and whether that can be explained by their heart rhythm. 'This smaller device allows us to measure at the moment up to 10 days 'The benefits of it are that it is smaller and more convenient, rather than different wires all over the place. 'We are able to put them on faster and we're able to reduce our turnaround times for reports and to get results back to patients faster.' The patch can monitor a person's heart rate for 10 to 14 days (Frimley Health NHS Foundation Trust/PA) He said that traditional Holter monitors are attached by trained physiologists but there is a shortage of these staff members at present. 'Because these are more straightforward, we've got specialist nurses who can be quite easily trained to apply them,' he added. Suzanne Jordan, associate director for medicine at Frimley Health, said the patches can even be sent out to patients for them to attach themselves. The feedback from the monitors are developed into reports for medics which are categorised in a traffic light system, she said. 'Green is perfectly fine – within normal limits; amber may need a clinician to review the report; red means potentially significant pauses or arrhythmia that need kind of an urgent review,' she said. 'It's been really positive – staff and patients really like it. 'We can post the patches to patients – there's explicit instructions there in terms of how to put it on, what to do if there's a problem, and also just to send it back as well. 'Once it comes back, it gets downloaded and the turnaround times are great.' Frimley Health NHS Foundation Trust said the move has been welcomed by patients and staff (Frimley Health NHS Foundation Trust/PA) Ms Jordan added: 'If you think of the bigger picture, it means that we're going to be able to manage our patients quickly. 'We've been running clinics by seeing maybe 30 patients in one day, whereas before, we were probably seeing 14 maximum – so we've kind of doubled our productivity. Asked about the conditions which will be monitored with the devices, Dr Sim added: 'Atrial fibrillation (AF) is a really important and common condition that we pick up with these devices, and we're increasingly looking at whether we can use them to help detect AF that's not symptomatic, and whether people are increased risk of stroke that we don't know about. 'The other conditions would relate to other forms of types of tachycardia, so fast heart rates, or episodes of very slow heart rates, such as heart blocks of different degrees, where patients may have palpitations or they may have fainting or syncope. 'So it allows us to monitor all of those heart rhythms.' On the use of AI to review the data from the monitors, he added: 'I think it's natural for everyone to be concerned whenever you put the term 'AI' into something, but these are pretty well tested algorithms that still have human oversight.' Mark Leftwich, managing director for Philips UK and Ireland, said: 'We're really excited to be working with Frimley Health to make heart monitoring easier and more comfortable for patients. 'Studies show Philips ePatch can spot up to 2.5 times more clinically relevant heart rhythm issues than the traditional Holter monitors – so not only is it more comfortable to wear, it can actually help catch issues that might have been missed before.'


South Wales Guardian
3 hours ago
- South Wales Guardian
DIY heart monitor rolled out to cut hospital waiting lists
Traditional monitors can require lengthy set-up by a trained physiologist, but the new kit can be sent out to patients in the post for them to attach themselves at home. The device looks like a small patch which is stuck to the skin, while traditional devices see patients hooked up to numerous wires and monitors. After the new tool is worn for a few days, patients can post the device back – which will cut out the need for appointments to fit and remove the equipment. The information from the monitor is then assessed using an artificial intelligence (AI) tool, Cardiologs, which produces a report which is then assessed by either a physiologist or a doctor. It can be used to investigate conditions include atrial fibrillation, tachycardia or heart blocks. Frimley Health NHS Foundation Trust is the first hospital in the country to roll out the device, with hopes that the device will soon be used across other NHS trusts. The Trust said it will still use traditional devices, known as Holter monitors, on some patients who are in hospital, but many of those who are outside of hospital will be able to access the new ePatch, which is made by Philips, to use in the comfort of their own homes. It has estimated that the use of the patches will double its productivity levels for diagnosing heart rhythm problems. Dr Iain Sim, consultant cardiac electrophysiologist, told the PA news agency: 'The purpose of the device is to record the heart rhythm – to collect electrical signals from the heart – and to try to understand a bit about the patient and what they are experiencing and whether that can be explained by their heart rhythm. 'This smaller device allows us to measure at the moment up to 10 days 'The benefits of it are that it is smaller and more convenient, rather than different wires all over the place. 'We are able to put them on faster and we're able to reduce our turnaround times for reports and to get results back to patients faster.' He said that traditional Holter monitors are attached by trained physiologists but there is a shortage of these staff members at present. 'Because these are more straightforward, we've got specialist nurses who can be quite easily trained to apply them,' he added. Suzanne Jordan, associate director for medicine at Frimley Health, said the patches can even be sent out to patients for them to attach themselves. The feedback from the monitors are developed into reports for medics which are categorised in a traffic light system, she said. 'Green is perfectly fine – within normal limits; amber may need a clinician to review the report; red means potentially significant pauses or arrhythmia that need kind of an urgent review,' she said. 'It's been really positive – staff and patients really like it. 'We can post the patches to patients – there's explicit instructions there in terms of how to put it on, what to do if there's a problem, and also just to send it back as well. 'Once it comes back, it gets downloaded and the turnaround times are great.' Ms Jordan added: 'If you think of the bigger picture, it means that we're going to be able to manage our patients quickly. 'We've been running clinics by seeing maybe 30 patients in one day, whereas before, we were probably seeing 14 maximum – so we've kind of doubled our productivity. Asked about the conditions which will be monitored with the devices, Dr Sim added: 'Atrial fibrillation (AF) is a really important and common condition that we pick up with these devices, and we're increasingly looking at whether we can use them to help detect AF that's not symptomatic, and whether people are increased risk of stroke that we don't know about. 'The other conditions would relate to other forms of types of tachycardia, so fast heart rates, or episodes of very slow heart rates, such as heart blocks of different degrees, where patients may have palpitations or they may have fainting or syncope. 'So it allows us to monitor all of those heart rhythms.' On the use of AI to review the data from the monitors, he added: 'I think it's natural for everyone to be concerned whenever you put the term 'AI' into something, but these are pretty well tested algorithms that still have human oversight.' Mark Leftwich, managing director for Philips UK and Ireland, said: 'We're really excited to be working with Frimley Health to make heart monitoring easier and more comfortable for patients. 'Studies show Philips ePatch can spot up to 2.5 times more clinically relevant heart rhythm issues than the traditional Holter monitors – so not only is it more comfortable to wear, it can actually help catch issues that might have been missed before.'